Literature DB >> 32315588

Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.

Mark Gluzman1, Jacob G Scott2, Alexander Vladimirsky3.   

Abstract

Recent clinical trials have shown that adaptive drug therapies can be more efficient than a standard cancer treatment based on a continuous use of maximum tolerated doses (MTD). The adaptive therapy paradigm is not based on a preset schedule; instead, the doses are administered based on the current state of tumour. But the adaptive treatment policies examined so far have been largely ad hoc. We propose a method for systematically optimizing adaptive policies based on an evolutionary game theory model of cancer dynamics. Given a set of treatment objectives, we use the framework of dynamic programming to find the optimal treatment strategies. In particular, we optimize the total drug usage and time to recovery by solving a Hamilton-Jacobi-Bellman equation. We compare MTD-based treatment strategy with optimal adaptive treatment policies and show that the latter can significantly decrease the total amount of drugs prescribed while also increasing the fraction of initial tumour states from which the recovery is possible. We conclude that the use of optimal control theory to improve adaptive policies is a promising concept in cancer treatment and should be integrated into clinical trial design.

Entities:  

Keywords:  Hamilton–Jacobi–Bellman equation; adaptive therapy; evolutionary game theory; optimal treatment policy; tumour heterogeneity

Mesh:

Year:  2020        PMID: 32315588      PMCID: PMC7211445          DOI: 10.1098/rspb.2019.2454

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.530


  44 in total

1.  Effective games and the confusion over spatial structure.

Authors:  Artem Kaznatcheev
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-14       Impact factor: 11.205

2.  Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model.

Authors:  Li You; Joel S Brown; Frank Thuijsman; Jessica J Cunningham; Robert A Gatenby; Jingsong Zhang; Kateřina Staňková
Journal:  J Theor Biol       Date:  2017-09-21       Impact factor: 2.691

Review 3.  Somatic clonal evolution: A selection-centric perspective.

Authors:  Jacob Scott; Andriy Marusyk
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-02       Impact factor: 10.680

4.  Optimization of an in vitro chemotherapy to avoid resistant tumours.

Authors:  Cécile Carrère
Journal:  J Theor Biol       Date:  2016-11-15       Impact factor: 2.691

5.  Acid-mediated tumor invasion: a multidisciplinary study.

Authors:  Robert A Gatenby; Edward T Gawlinski; Arthur F Gmitro; Brant Kaylor; Robert J Gillies
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

6.  Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

Authors:  T Browder; C E Butterfield; B M Kräling; B Shi; B Marshall; M S O'Reilly; J Folkman
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

7.  Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients.

Authors:  Emilie Hénin; Christophe Meille; Dominique Barbolosi; Benoit You; Jérôme Guitton; Athanassios Iliadis; Gilles Freyer
Journal:  Breast Cancer Res Treat       Date:  2016-03-22       Impact factor: 4.872

8.  Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game.

Authors:  D Basanta; J G Scott; M N Fishman; G Ayala; S W Hayward; A R A Anderson
Journal:  Br J Cancer       Date:  2011-12-01       Impact factor: 7.640

9.  Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance.

Authors:  Daniel Nichol; Peter Jeavons; Alexander G Fletcher; Robert A Bonomo; Philip K Maini; Jerome L Paul; Robert A Gatenby; Alexander R A Anderson; Jacob G Scott
Journal:  PLoS Comput Biol       Date:  2015-09-11       Impact factor: 4.475

10.  Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance.

Authors:  Jeff Maltas; Kevin B Wood
Journal:  PLoS Biol       Date:  2019-10-25       Impact factor: 8.029

View more
  8 in total

Review 1.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

Review 2.  The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer.

Authors:  Benjamin Wölfl; Hedy Te Rietmole; Monica Salvioli; Artem Kaznatcheev; Frank Thuijsman; Joel S Brown; Boudewijn Burgering; Kateřina Staňková
Journal:  Dyn Games Appl       Date:  2021-08-30       Impact factor: 1.296

3.  In Silico Investigations of Multi-Drug Adaptive Therapy Protocols.

Authors:  Daniel S Thomas; Luis H Cisneros; Alexander R A Anderson; Carlo C Maley
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

4.  IsoMaTrix: a framework to visualize the isoclines of matrix games and quantify uncertainty in structured populations.

Authors:  Jeffrey West; Yongqian Ma; Artem Kaznatcheev; Alexander R A Anderson
Journal:  Bioinformatics       Date:  2020-12-16       Impact factor: 6.937

5.  Modelling bistable tumour population dynamics to design effective treatment strategies.

Authors:  Andrei R Akhmetzhanov; Jong Wook Kim; Ryan Sullivan; Robert A Beckman; Pablo Tamayo; Chen-Hsiang Yeang
Journal:  J Theor Biol       Date:  2019-05-09       Impact factor: 2.405

6.  Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer.

Authors:  Jessica Cunningham; Frank Thuijsman; Ralf Peeters; Yannick Viossat; Joel Brown; Robert Gatenby; Kateřina Staňková
Journal:  PLoS One       Date:  2020-12-08       Impact factor: 3.240

7.  Dosage strategies for delaying resistance emergence in heterogeneous tumors.

Authors:  Vahideh Vakil; Wade Trappe
Journal:  FEBS Open Bio       Date:  2021-03-30       Impact factor: 2.693

8.  Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules.

Authors:  Grant R Howard; Tyler A Jost; Thomas E Yankeelov; Amy Brock
Journal:  PLoS Comput Biol       Date:  2022-03-31       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.